Adam Akhtar is a seasoned professional in the field of pharmacovigilance and patient safety, currently serving as the Director of Benefit-Risk Science & Process at Gilead Sciences since April 2017. With extensive experience in risk management and medical surveillance, Adam has held various roles in leading pharmaceutical companies, including Principal PV Scientist at AstraZeneca and Manager of Drug Safety & Public Health at Gilead Sciences. Adam's expertise encompasses signal detection, risk management plan authoring, and regulatory submission support, particularly within HIV and HCV therapy areas. Adam's educational background includes a Postgraduate Certificate in Pharmacoepidemiology and Pharmacovigilance from the London School of Hygiene and Tropical Medicine and a BSc in Pharmacology from King's College London.
This person is not in any teams
This person is not in any offices